The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Daiichi Sankyo profit rises 46.9% as cancer-drug sales boost first half

Oct 30, 2026 05:26 (9h ago)

Verifying

Daiichi Sankyo reported stronger first-half earnings, led by its oncology business.
Core operating profit increased 46.9% to 221.3 billion yen in six months.
Daiichi Sankyo maintained fiscal 2026 forecasts and planned a higher annual dividend.